Valeant CLENZIderm Acne Treatment Recall: Discoloration Risk
Valeant recalls 5 fl oz salicylic acid acne treatment due to potential discoloration. Learn if your product is affected and what to do.
Lower-risk recall
Discoloration.
Contact the company
What happened, in plain English
Valeant is recalling a specific acne treatment product because it may cause discoloration. This issue does not pose a health risk but could affect skin appearance. Read more at govinfonow.com/recall/41799-valeant-clenziderm-acne-treatment-recall-discoloration-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/41799-valeant-clenziderm-acne-treatment-recall-discoloration-risk · Updated October 8, 2026 · FDA enforcement record: FDA #D-0672-2017
Cite this page
“Valeant CLENZIderm Acne Treatment Recall: Discoloration Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41799-valeant-clenziderm-acne-treatment-recall-discoloration-risk. Based on FDA recall #D-0672-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0672-2017%22&limit=1).
Why it’s dangerous
The product may cause skin discoloration as a result of its salicylic acid content. This discoloration is not harmful but could be noticeable on the skin.
Who’s affected
People who own or use the recalled CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL) product are affected. Those with sensitive skin may be at slightly higher risk of visible discoloration.
How to tell if you have this one
Check for the product name 'CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL)' on the label. The product was distributed by OMP, Inc. in Long Beach, CA and made in the USA.
- Brand
Valeant- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0672-2017 | CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL), Valeant Pharmaceuticals North America LLC Distributed by OMP, Inc Long Beach, CA 90806 Made in USA. Product SKU 301876102042, NDC 0187-6102-04; Lot #: 15J1277, Exp. 04/2017 | 38,767 units |
| D-0673-2017 | CLENZIderm M.D. Acne Treatment System, kit has 3 bottles a) Therapeutic Lotion (benzoyl peroxide 5% Acne Treatment) 47mL bottle, b) Daily Care Foaming Cleanser (Salicylic Acid 2% Acne Treatment) 118 mL bottle, c) Salicylic Acid 2% Acne Treatment 148mL, Valeant Pharmaceuticals North America LLC Distributed by OMP, Inc Long Beach, CA 90806 Made in USA, Product SKU 301876103018, NDC 0187-6103-01; Lot #: a) 15I1234, Exp. 09/18, b) 15E1221, Exp. 09/18, c) 15G1235 and 15I1236, Exp. 09/18. | 5,647 units |
What to do — step by step
Check Product Label
Look for the product name and SKU number 301876102042 on the label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
Yes, the product is safe for use but may cause discoloration in some users.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0672-2017 (March 20, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0672-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.